Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG40777

EHD1 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The EHD1 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9?mediated polyclonal knockout cell population derived from HEK293T human embryonic kidney epithelial cells. This model disrupts EHD1, a dynamin?like ATPase that controls endocytic recycling, affecting the trafficking of key receptors such as the transferrin receptor and beta1 integrin. EHD1 functions downstream of EGF and insulin and forms complexes with Rab11, MICAL?L1, and Syndapin. The polyclonal knockout population is ideal for investigating receptor recycling, cell migration, and membrane trafficking using assays like transferrin uptake, immunofluorescence, and co?immunoprecipitation. Applications span cancer cell migration studies, drug delivery optimization, and analysis of clathrin?independent endocytosis pathways.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    EHD1

    Gene Identifier

    NCBI Gene ID 10938

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The EHD1 Knockout HEK293T Polyclonal Cells constitute a CRISPR/Cas9-mediated gene-disrupted polyclonal knockout cell population targeting the EHD1 locus in the HEK293T human embryonic kidney epithelial cell line. This product provides a loss-of-function model generated through CRISPR/Cas9 genome editing, yielding a heterogeneous pool of edited cells suitable for studying the cellular consequences of impaired endocytic recycling. As a polyclonal population, it avoids the clonal variation often associated with single-cell-derived knockouts, offering a broadly representative mutant cell pool for functional analyses.

HEK293T cells, a derivative of the original HEK293 line, are immortalized adherent epithelial cells transformed with sheared adenovirus 5 DNA. They stably express the SV40 large T antigen, which drives episomal amplification of plasmids bearing the SV40 origin, making them a premier host for transient protein expression and efficient lentivirus production. The cell line??s robust growth, high transfection efficiency, and well-characterized signaling milieu underpin its widespread use in cell biology and drug discovery.

EHD1 is a dynamin-like ATPase that orchestrates endocytic recycling by promoting fission of tubular carriers from early endosomes, facilitating the return of internalized receptors and lipids to the plasma membrane. It operates within a network that includes upstream regulators such as EGF and insulin, interacting partners like Rab11, MICAL-L1, Syndapin, and the EHD paralogs EHD2, EHD3, and EHD4, and downstream targets including the transferrin receptor, beta1 integrin, and various GPCRs. EHD1-dependent recycling is essential for maintaining plasma membrane receptor composition and supporting processes such as cell migration and signal transduction.

In HEK293T cells, disruption of EHD1 function impairs the efficient re?presentation of the transferrin receptor and beta1 integrin at the cell surface, leading to defects in iron uptake and integrin-dependent adhesion and migration. Given the HEK293T cell??s role as a workhorse for recombinant protein production and viral packaging, the knockout model also provides a platform to examine how membrane trafficking perturbations influence protein expression, secretion, and lentivirus vector assembly.

This polyclonal knockout cell product enables a wide array of research applications, including quantitative transferrin uptake and recycling assays, receptor internalization kinetics, cell migration analyses, and co?immunoprecipitation studies to map EHD1 interactomes. It is well suited for probing clathrin-independent endocytosis, GPCR trafficking, and the impact of recycling defects on cancer cell motility or drug delivery strategies. For additional details and ordering information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)